Article
US FDA approves Valneva's chikungunya vaccine
Rating:
0.0
Views:
43
Likes:
1
Library:
1
The U.S. Food and Drug Administration (FDA) on Thursday approved Valneva's single-shot vaccine for individuals 18 years of age and older who are at increased risk of exposure to the chikungunya virus.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value